Skip to content

Illinois dispensary to allow patients to substitute medical marijuana for opioids prescription

January 31, 2019 / Arfinn Med MD /

Illinois dispensary to allow patients to substitute medical marijuana for opioids prescription

SPRINGFIELD, ILL. (KMOV.com) — Thursday, Illinois will become the first state to launch a revised medical marijuana program.

The program allows pain suffers who use opioids to temporarily switch to medical marijuana. Following months of planning, the new initiative will launch at the HCI Alternatives medical cannabis dispensary in Springfield, Illinois.

In a press release, the Health Central Illinois Alternatives said the program will be the first of its kind in the United States.

“This program will open the door to thousands of Illinoisans who don’t want to use dangerously addictive opioids to manage their pain,” said HCI Alternatives CEO Chris Stone.  “Our staff is ready to educate new patients about their options and walk them through the process. We have also worked with our cultivation partners to ensure we have enough product to handle the expected patient increase over the next several months,” Read the full article here.

Stories you may be interested in

Substance in cannabis ‘could boost pancreatic cancer treatments’

A substance found in cannabis plants might boost treatments for patients with pancreatic cancer, research in mice has suggested. Cannabidiol, or CBD, is not psychoactive, meaning it does not produce feelings of being high in those who take it. It is extracted from hemp plants and is legal in the UK, although a CBD product…
Read More →

Medical marijuana advocates concerned over recreational cannabis proposals

ALBUQUERQUE, N.M.— Some medical marijuana patients are concerned the proposed framework for legalizing recreational marijuana could have a potentially negative impact on the medical cannabis program. “It’s something that will devastate the medical program in doing so,” said Jason Barker, a medical cannabis advocate with Safe Access New Mexico. A special task force delivered a…
Read More →

Study on cannabis chemical as a treatment for pancreatic cancer may have ‘major impact,’ Harvard researcher says

Pancreatic cancer makes up just 3 percent of all cancers in America. But with a one-year survival rate of just 20 percent (and five-year survival rate of less than 8), it’s predicted to be the second leading cause of cancer-related death by 2020. Headlines about the illness, as a result, tend to be discouraging. But this month scientists from Harvard University’s Dana-Farber…
Read More →

Survey of oncologists finds knowledge gap on medical marijuana

As more states legalize medical marijuana, two key groups — researchers whose job is it to understand its benefits and drawbacks, and physicians charged with advising potential users — are struggling to catch up with policymakers. Ilana Braun, an assistant professor of psychiatry at Harvard Medical School and chief of the division of adult psychosocial…
Read More →

Thanks to the Farm Bill, Hemp Is Legal. Here’s What It Means for CBD.

On Tuesday, the Senate voted to approve a new an $867 billion farm bill, and on Wednesday, it passed in Congress. While the bill has plenty of positive merits, the one people are perhaps most excited about is the fact that it will legalize the production, sale, and distribution of industrial hemp at a federal…
Read More →

COVID-19 and medical cannabis patients: What you need to know

In the midst of the COVID-19 maelstrom, the recent shuttering of nonessential stores has created concern around access to cannabis, particularly for medicinal cannabis consumers. Those who depend on cannabis for therapeutic purposes will be relieved to learn that across the US, medical cannabis dispensaries have been deemed essential services, comparable to pharmacies. As of March…
Read More →

Leave a Comment

You must be logged in to post a comment.